Cannabinoid CB1 receptor expression in rat spinal cord

被引:216
作者
Farquhar-Smith, WP
Egertová, M
Bradbury, EJ
McMahon, SB
Rice, ASC
Elphick, MR
机构
[1] Imperial Coll, Sch Med, Dept Anaesthet, Pain Res Grp, London W2 1NY, England
[2] Univ London Queen Mary & Westfield Coll, Sch Biol Sci, London E1 4NS, England
[3] Guys Kings & St Thomas Sch Biomed Sci, Dept Physiol, London SE1 7EH, England
基金
英国惠康基金;
关键词
D O I
10.1006/mcne.2000.0844
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
While evidence implicates the endogenous cannabinoid system as a novel analgesic target at a spinal level, detailed analysis of the distribution of the cannabinoid receptor CB1 in spinal cord has not been reported. Here, immunocytochemical studies were used to characterize the CB1 receptor expression in rat spinal cord. Staining was found in the dorsolateral funiculus, the superficial dorsal horn (a double band of CB1 immunoreactivity (ir) in laminae I and II inner/III transition), and lamina X. Although CB1-ir was present in the same laminae as primary afferent nociceptor markers, there was limited colocalization at an axonal level. Interruption of both primary afferent input by dorsal root rhizotomy and descending input by rostral spinal cord hemisection produced minor changes in CB1-ir. This and colocalization of CB1-ir with interneurons expressing protein kinase C subunit gamma-ir suggest that the majority of CB1, expression is on spinal interneurons. These data provide a framework and implicate novel analgesic mechanisms for spinal actions of cannabinoids at the CB1 receptor.
引用
收藏
页码:510 / 521
页数:12
相关论文
共 61 条
  • [1] PERIPHERAL ADMINISTRATION OF NERVE GROWTH-FACTOR IN THE ADULT-RAT PRODUCES A THERMAL HYPERALGESIA THAT REQUIRES THE PRESENCE OF SYMPATHETIC POSTGANGLIONIC NEURONS
    ANDREEV, NY
    DIMITRIEVA, N
    KOLTZENBURG, M
    MCMAHON, SB
    [J]. PAIN, 1995, 63 (01) : 109 - 115
  • [2] ASHTON CH, 1997, THERAPEUTIC USES CAN
  • [3] NGF but not NT-3 or BDNF prevents the A fiber sprouting into lamina II of the spinal cord that occurs following axotomy
    Bennett, DLH
    French, J
    Priestley, JV
    McMahon, SB
    [J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 1996, 8 (04) : 211 - 220
  • [4] BIRDER LA, 1992, J NEUROSCI, V12, P4878
  • [5] Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells
    Bisogno, T
    Sepe, N
    Melck, D
    Maurelli, S
    DePetrocellis, L
    DiMarzo, V
    [J]. BIOCHEMICAL JOURNAL, 1997, 322 : 671 - 677
  • [6] Control of pain initiation by endogenous cannabinoids
    Calignano, A
    La Rana, G
    Giuffrida, A
    Piomelli, D
    [J]. NATURE, 1998, 394 (6690) : 277 - 281
  • [7] CANNABINOID RECEPTOR AGONISTS INHIBIT CA CURRENT IN NG108-15 NEUROBLASTOMA-CELLS VIA A PERTUSSIS TOXIN-SENSITIVE MECHANISM
    CAULFIELD, MP
    BROWN, DA
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1992, 106 (02) : 231 - 232
  • [8] DEADWYLER SA, 1995, J PHARMACOL EXP THER, V273, P734
  • [9] DEVANE WA, 1988, MOL PHARMACOL, V34, P605
  • [10] ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR
    DEVANE, WA
    HANUS, L
    BREUER, A
    PERTWEE, RG
    STEVENSON, LA
    GRIFFIN, G
    GIBSON, D
    MANDELBAUM, A
    ETINGER, A
    MECHOULAM, R
    [J]. SCIENCE, 1992, 258 (5090) : 1946 - 1949